MyLungCancerTeam

The KRAS mutation is actually quite common, occurring in up to 30% of people with non-small cell lung cancer (NSCLC). This mutation affects how cells grow and divide by keeping certain processes turned on when they should naturally cycle on and off. One MyLungCancerTeam member shared a similar experience to yours, having Show Full Answer

The KRAS mutation is actually quite common, occurring in up to 30% of people with non-small cell lung cancer (NSCLC). This mutation affects how cells grow and divide by keeping certain processes turned on when they should naturally cycle on and off. One MyLungCancerTeam member shared a similar experience to yours, having successful surgery to remove a nodule. They had robotic-assisted surgery to remove the nodule along with surrounding lymph nodes. While they ended up needing some preventive chemotherapy due to the nodule's location, many early-stage patients like yourself may not need additional treatment after surgery. If you ever need additional treatment options in the future, there are now targeted therapies specifically for KRAS mutations, including medications like Krazati and Lumakras. This is considered a breakthrough since KRAS mutations were previously thought to be untreatable with targeted therapies.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Lung Cancer Treatment Options

LUNGevity Launches First of Six Resource Portals for Specific Types of Lung Cancer